title: Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes.
authors.affiliation: Department of Cardiology, Rambam Medical Center, Haifa, Israel.
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Sulieman
authors.forename: Rabea
authors.initials: R
authors.lastname: Asleh
authors.forename: Zvi I
authors.initials: ZI
authors.lastname: Cabantchik
authors.forename: William
authors.initials: W
authors.lastname: Breuer
authors.forename: Doron
authors.initials: D
authors.lastname: Aronson
authors.forename: Abeer
authors.initials: A
authors.lastname: Suleiman
authors.forename: Rachel
authors.initials: R
authors.lastname: Miller-Lotan
authors.forename: Haim
authors.initials: H
authors.lastname: Hammerman
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Levy
mesh_terms: D016022:Case-Control Studies; D048909:Diabetes Complications / Q000097:blood* / Q000401:mortality*; D003920:Diabetes Mellitus / Q000097:blood; D006801:Humans; D007501:Iron / Q000097:blood*; D009203:Myocardial Infarction / Q000097:blood* / Q000401:mortality*; D010084:Oxidation-Reduction; D011237:Predictive Value of Tests; D011446:Prospective Studies
chemical_list: D007501:Iron